On Nov. 21, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that by the week ending November 9, 2024, an estimated 34.7% of adults aged ≥18 years reported having received an influenza vaccine, and 17.9% reported having received a COVID-19 vaccine for the 2024–25 respiratory virus season.

Nearly 40% of adults aged ≥75 years, and 31.6% of adults aged 60–74 years at increased risk for severe RSV, had ever received an RSV vaccine. Coverage with all vaccines was lowest among uninsured persons, and high percentages of those without insurance reported that they probably or definitely will not receive influenza vaccine (43.6%) or COVID-19 vaccine (44.3%).

Early season estimates of vaccination coverage among U.S. adults with influenza, COVID-19, and RSV vaccines are low and indicate that many adults lack the protection from respiratory virus infections afforded by vaccines. However, many unvaccinated adults reported that they definitely or probably will get vaccinated or were unsure, suggesting they are open to vaccination.